An efficacy comparison between a combination of 308-nm excimer light and 5% liquor carbonis detergens cream with 5% liquor carbonis detergens cream alone in the treatment of chronic, mild plaque-type psoriasis
Abstract:
Psoriasis is a chronic immune-mediated inflammatory skin disease associated with systemic inflammation and an elevated risk of arterial stiffness and cardiovascular diseases. This study aimed to (1) compare arterial stiffness and cardiovascular risk factors between psoriatic and non-psoriatic individuals by Cardio-Ankle Vascular Index (CAVI), and (2) evaluate the clinical efficacy of Hibiscus sabdariffa L. (Roselle) calyces extract in improving arterial stiffness and cardiovascular risk parameters in patients with plaque psoriasis.
In the comparative study, 26 psoriatic patients were assessed against a compare group using the CAVI. The results showed a significantly higher CAVI in the psoriasis group (OR = 10.73, 95% CI: 3.9828.87, p < 0.05), along with elevated fasting glucose, triglycerides, and LDL cholesterol compared to controls.
Subsequently, a single-arm clinical trial was conducted in the same 26 psoriatic patients, who received 3,000 mg/day of Roselle extract for 12 weeks. Significant reductions in CAVI were observed (from 8.37 ± 0.70 to 7.67 ± 0.70, p < 0.001), along with reductions in body weight, BMI, blood pressure, fasting glucose, total cholesterol, triglycerides, LDL, hs-CRP, and creatinine. GFR significantly improved, while HDL, AST, and HbA1C showed no significant changes. ALT increased slightly.
This study conclude that psoriatic patients are at higher risk for atherosclerosis and cardiovascular complications which can screen by CAVI. Roselle extract may serve as a beneficial adjunct therapy in managing cardiovascular risk in this population.